PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

JP Morgan Private Capital closes first biotech VC fund above $500m

JP Morgan Private Capital, JP Morgan’s venture capital and growth equity investment team has held the final close of 270 Life Sciences Private Capital Fund I, above its $500m target. 

LSPCF received commitments from institutional allocators, strategic corporate partners, family offices and HNWIs across North America, Europe, the Middle East and Asia, as well as JPMorgan Chase & Co. The fund close was led by CIO Stephen Squinto and Managing Partner Gaurav Gupta. 

LSPCF invests in private biotechnology companies spanning cardiometabolic disease, oncology, immunology and genetic medicines. 

 

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured